Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivo

Pharmaceutical Research

Volumn 14, Issue 9, 1997, Pages 1223-1227

  Okumura, Katsuhiko ^a   Nishiguchi, Kohshi ^a   Tanigawara, Yusuke ^a   Mori, Sachiko ^b   Iwakawa, Seigo ^b   Komada, Fusao ^a  

^a KOBE UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Carrageenin; Cell transplantation; Gene therapy; Paw edema; SOD; Xanthine xanthine oxidase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL TRANSFORMATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE THERAPY; NONHUMAN; OXIDATIVE STRESS; PAW EDEMA; PRIORITY JOURNAL; RAT; SKIN FIBROBLAST; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CARRAGEENAN; CELL LINE; DRUG DELIVERY SYSTEMS; EDEMA; EXCIPIENTS; FIBROBLASTS; GENE THERAPY; HUMANS; RATS; SKIN; SUPEROXIDE DISMUTASE;

EID: 0030848035     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012115109525     Document Type: Article

References (25)

1. I. Fridovich J. Biol. Chem. 264:7761-7764 (1989).
2. J. M. McCord. J. Free Radicals Biol. 4:9-14 (1988).
3. W. F. Petrone, D. K. English, K. Wong, and J. M. McCord. Proc. Natl. Acad. Sci. USA 77:1159-1163 (1980).
4. O. I. Pisarenko, I. M. Studneva, V. L. Lakomkin, A. A. Timohin, and V. I. Kapelko. J. Cardiovasc. Pharmacol. 24:655-663 (1994).
5. N. Taniguchi. Adv. Clin. Chem. 29:1-59 (1992).
6. G. Jadot, A. Vaille, J. Maldonado, and P. Vanelle. Clin. Pharmacokinet. 28:17-25 (1995).
7. R. I. Garver, Jr., A. Chytil, M. Courtney, and R. G. Crystal. Science 237:762-764 (1987).
8. R. F. Selden, M. J. Skoskiewicz, K. B. Howie, P. S. Russell, and H. M. Goodman. Science 236:714-718 (1987).
9. F. Komada, K. Nishiguchi, Y. Tanigawara, M. Ishida, X.-Y. Wu, S. Iwakawa, R. Sasada and K. Okumura. Biol. Pharm. Bull. 20:530-536 (1997).
10. K. Nishiguchi, F. Komada, K. Ishida, M. Nakajima, T. Maeda, S. Iwakawa, Y. Tanigawara, and K. Okumura. Biol. Pharm. Bull. 19:1073-1077 (1996).
11. K. Nishiguchi, Y. Kiyohara, F. Komada, S. Iwakawa, and K. Okumura. Pharm. Res. 11:1244-1249 (1994).
12. Y. Oyanagui. Anal. Biochem. 142:290-296 (1984).
13. R. Vinegar, W. Schreiber, and R. Hugo. J. Pharmacol. Exp. Ther. 166:96-103 (1969).
14. T. Ogino, M. Inoue, Y. Ando, A. Awai, H. Maeda, and Y. Morino. Int. J. Pept. Protein Res. 32:153-159 (1988).
15. P. S. Pyatak, A. Abuchowski, and F. F. Davis. Res. Commun. Chem. Pathol. Pharmacol. 29:113-127 (1980).
16. R. A. Hallewell, I. Laria, A. Tabrizi, G. Carlin, E. D. Getzoff, J. A. Tainer, L. S. Cousens, and G. T. Mullenback. J. Biol. Chem. 264:5260-5268 (1989).
17. R. Sasada, R. Marumoto, and K. Igarashi. Cell Struct. Func. 13:129-141 (1988).
18. P. H. Chan, G. Y. Yang, S. F. Chen, E. Carlson, and C. J. Epstein. Ann. Neurol. 29:482-486 (1991).
19. P. Amstad, A. Peskin, G. Shah, M.-E. Mirault, R. Moret, I. Zbinden, and P. Cerutti. Biochemistry 30:9305-9313 (1991).
20. I. S. Ayene, C. Dodia, and A. B. Fisher. Arch. Biochem. Biophys. 296:183-189 (1992).
21. Y. Oyanagui. Biochem. Pharmacol. 25:1456-1472 (1976).
22. N. K. Boughton-Smith, A. M. Deakin, R. L. Follenfant, B. J. R. Whittle, and L. G. Garland. Br. J. Parmacol. 110:896-902 (1993).
23. M. Hughes, A. Vassilakos, D. W. Andrew, G. Hortelano, J. W. Belmont, and P. L. Chang. Hum. Gene Ther. 5:1445-1455 (1994).
24. C. G. Cochrane, R. spragg, and S. D. Revak. J. Clin. Invest. 71:754-761 (1983).
25. H.-X. Deng, A. Hentati, J. A. Tainer, Z. Iqbal, A. Cayabyab, W. Y. Hung, E. D. Getzoff, P. Hu, B. Herzfeld, R. P. Roos, C. Warner, G. Deng, E. Soriano, C. Smyth, H. E. Parge, A. Ahmed, A. D. Roses, R. A. Hallewell, M. A. Pericak-Vance, and T. Siddique. Science 261:1047-1051 (1993).